NUVB
Nuvation Bio Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +5.9% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +2 | 157.38M | $893.56M | +5 | −3 |
| Q1 2026 | 98 | +3 | 147.71M | $634.66M | +12 | −9 |
| Q4 2025 | 94 | +2 | 141.34M | $1.26B | +2 | — |
| Q3 2025 | 19 | +1 | 120.52M | $443.85M | +2 | −1 |
| Q2 2025 | 15 | 0 | 120.03M | $233.06M | +1 | −1 |
| Q1 2025 | 12 | -1 | 18.55M | $32.01M | — | −1 |
| Q4 2024 | 13 | 0 | 18.40M | $47.86M | — | — |
| Q3 2024 | 12 | +1 | 12.76M | $28.26M | +1 | — |
| Q2 2024 | 11 | — | 9.41M | $26.24M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 4.95M | +22.9% | $13.17M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 4.95M | +22.9% | $13.17M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 4.60M | — | $12.24M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Millennium Management ✦ | 2.48M | +82.7% | $6.59M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 2.25M | -20.5% | $5.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 2.25M | -20.5% | $5.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 2.25M | -20.5% | $5.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 2.25M | -20.5% | $5.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 1.15M | +0.5% | $3.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 821.36K | +10.6% | $2.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 821.36K | +10.6% | $2.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 821.36K | +10.6% | $2.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 676.02K | +8.3% | $1.80M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 676.02K | +8.3% | $1.80M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 566.80K | -44.9% | $1.51M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 226.82K | -18.0% | $603,352 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 225.03K | +4.5% | $599,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 47.40K | -57.4% | $126,084 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 47.40K | -57.4% | $126,084 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Greenlight Capital (DME Capital) ✦ | 135.00K | 0.0% | $116,087 | 0.0% | Held | 3 | SEC ↗ |
| 21 | Greenlight Capital (DME Capital) ✦ | 135.00K | 0.0% | $116,087 | 0.0% | Held | 3 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 266.67K | 0.0% | $61,333 | 0.0% | Held | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 230 holders, 219.97M shares, $906.24M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 100.00K sh · $709,240
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology